Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hubei Shubang Pharmaceutical is a specialized pharmaceutical manufacturer based in China, focusing on the development and production of active pharmaceutical ingredients (APIs) and advanced chemical intermediates. Founded in 2012, the company operates a state-of-the-art manufacturing facility in Tianmen, Hubei, which adheres to international GMP standards. Shubang Pharmaceutical is recognized for its expertise in complex chemical synthesis, particularly in the fields of antiviral, cardiovascular, and central nervous system therapeutics. The company provides comprehensive CDMO services, including process optimization and custom synthesis, to a global clientele. Its product portfolio features key intermediates for widely used medications such as Favipiravir and various modern anticoagulants.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hubei Shubang Pharmaceutical.